Diabetic patients - General practice standards of care in two regions in Norway;Diabetesomsorg i norsk allmennpraksis: En tilstandsrapport fra Saiten og deler av Rogaland

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 25, 1997, Pages 3661-3664

  Claudi, Tor ^a   Cooper, John ^b   Skogæy, Kristin ^a,b   Hausken, Marie Fjelde ^b   Melbye, Hasse ^c  

^a Rønvik Legesenter   (Norway)

^b Hjelmeland Legekontor ^*  (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PATIENT SATISFACTION; STANDARD; STATISTICS;

ADULT; AGED; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PATIENT SATISFACTION; QUALITY OF HEALTH CARE;

EID: 0031580906     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Diabetes Control and Complication Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1994; 14: 977-86.
2. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-68.
3. Andersson DKG, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43.
4. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Mytoyshi S et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-17.
5. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin dependent diabetes mellitus. Ann Int Med 1996; 124: 136-45.
6. Yudkin JS. How can we best prolong life? Benefits of coronary risk reduction in non-diabetic and diabetic subjects. BMJ 1993; 306: 1313-8.
7. Falkenberg M. Förbättrad diabetesvård i primärvården ger minskad antal amputasjoner. Läkartidningen 1989; 41: 3450-3.
8. Claudi T, Midthjell K, Øgar P, Hestvold P-I, Furuseth K, Hanssen KF. Kvalitetssikring av samhandling/arbeidsfordeling mellom primærhelsetjenesten og annenlinjetjenesten. Tidsskr Nor Lægeforen 1992; 112: 3555-9.
9. Claudi T, Midthjell K, Furuseth K, Hanssen KF, Hestvold P-I, Øgar P. NSAM's handlingsprogram for diabetes i allmennpraksis. Oslo: Norsk selskap for allmennmedisin, Norges Diabetesforbund, Statens Helsetilsyn, Statens institutt for folkehelse, Den norske lasgeforenine, 1995.
10. Dunn NR, Bough P. Standards of care of diabetic patients in a typical English community. Br J Gen Pract 1996; 46: 401-5.
11. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996; 313: 779-84.
12. Panzram G. Mortality and survival in type 2-diabetes mellitus. Diabetologia 1987; 30: 123-31.
13. Mühlhauser I. Smoking and diabetes. Diabet Med 1990; 7: 10-5.
14. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med 1996; 335: 1001-9.
15. Holmen J, Aursnes I, Forsdal A, Hetlevik I, Hjermann I, Hjort P et al. Høyt blodtrykk. NSAM's handlingsprogram. Rapport U3 1993. Verdal: Samfunnsmedisinsk forskningssenter, Folkehelsa, 1993.
16. Terapianbefaling, behandling av hyperlipidemi. Nytt fra Statens legemiddelkontroll 1995; 18: nr. 7.